Literature DB >> 31395407

Fatalities related to new psychoactive substances in Singapore-A case series.

Shijia Chan1, Jiahao Wu2, Belinda Lee3.   

Abstract

The use of New Psychoactive Substances (NPS) has become a serious global issue with increasing number of reports of their toxicities and fatalities. Likewise, in Singapore, the number of exhibits containing NPS detected had increased 80% from 2011 to 2014. This is a case series of the first four autopsy cases of fatalities due to or related to the use of NPS in Singapore. In one case, we present the first reported case of death due directly to ADB-FUBINACA toxicity (post-mortem blood concentration of 56ng/ml). Another case was due to 25B-NBOMe toxicity (post-mortem blood concentration of 10ng/ml) while the last two cases were deaths related to 5-Fluoro ADB, where the metabolites of the drug were detected.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  25B-NBOMe; 5-Fluro ADB; ADB-FUBINACA; Autopsy; New psychoactive substance; Synthetic cannabinoids

Mesh:

Substances:

Year:  2019        PMID: 31395407     DOI: 10.1016/j.forsciint.2019.109892

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

Review 1.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

2.  Accidental Ingestion of a Novel Psychoactive Substance: A Case Report.

Authors:  Abhay Kant; Rupeng Mong; Hock Heng Tan
Journal:  Cureus       Date:  2020-10-26

Review 3.  Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.

Authors:  Carolina Lobato-Freitas; Andreia Machado Brito-da-Costa; Ricardo Jorge Dinis-Oliveira; Helena Carmo; Félix Carvalho; João Pedro Silva; Diana Dias-da-Silva
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.